Clinical Trial Update: Ocular Hypotensive Efficacy of AR-102 [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the ocular hypotensive efficacy of AR-102 in glaucoma has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• AR-102

Snippet

Sponsor: Aerie Pharmaceuticals | Conditions: Glaucoma | Phase 2 | Status: COMPLETED